Ayer Capital Management, LP

person

Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.

Political giving

—

Political receipts

—

Lobbying income

—

Lobbying expense

—

Federal awards

—

Relationships

Connected records

Relationship	Connected entity	Amount / weight	Period
insider of	Inc. Iovance Biotherapeutics	28,004,435	May 22, 2013 – May 22, 2013
insider of	Cascadian Therapeutics, Inc.	252,586	Jun 23, 2011 – Jun 23, 2011

Source coverage

sec insider: 0001471149

Ayer Capital Management, LP — Influence Profile | Poliscope